When was NeuroVision founded?

NeuroVision was founded in 2010 and raised its 1st funding round 3 years after it was founded.

Where is NeuroVision located?

NeuroVision is headquartered in Sacramento, United States. It is registered at Sacramento, California.

Who is the current CEO of NeuroVision?

Steven Verdooner of NeuroVision. They have also founded 2 companies.

How many employees does NeuroVision have?

As of Aug 31, 2026, the latest employee count at NeuroVision is 23.

Is NeuroVision a funded company?

NeuroVision is a funded company, having raised a total of $20.4M across 7 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 15, 2013.

When was the latest funding round of NeuroVision?

NeuroVision's latest funding was a $***** Series C round on Aug 24, 2021, with participation from 1 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $6.5B in funding in 2026 to date.

Where does NeuroVision rank among its competitors?

NeuroVision ranks 1st amongst 54 active competitors, of which 18 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Stata DX, which secured $1.89M in Feb, 2026.

Who are the top competitors of NeuroVision?

NeuroVision's top competitors include Augmental Tech, Openwater and BrainSpace. Among them, Stata DX secured the most recent funding round in February, 2026.

NeuroVision - 2026 Company Profile, Team, Funding & Competitors

NeuroVision is a series C company based in Sacramento (United States), founded in 2010 by Steven Verdooner. It operates as a Provider of telehealth platform offering diagnostic and preventative neurology services. NeuroVision has raised $20.4M in funding from Wildcat Capital Management. The company has 54 active competitors, including 18 funded and 2 that have exited. Its top competitors include companies like Augmental Tech, Openwater and BrainSpace.

Company Details

Provider of telehealth platform offering diagnostic and preventative neurology services. The platform addresses gaps in diagnostic and care pathways for cognitive conditions. It screens and triages patients into appropriate healthcare provider workflows. The companys proprietary Afina retinal imaging platform with AI software detects amyloid signatures in the retina for early Alzheimers detection and prediction of cerebral amyloid angiopathy and treatment-related side effects.

Website: www.neurovision.com/
Registered Address: Sacramento, California

Key Metrics

Founded Year

2010

Location

Sacramento, United States

Stage

Series C

Total Funding

$20.4M in 7 rounds

Latest Funding Round

Series C, Aug 24, 2021, $*****

Investors

Wildcat Capital Management & 7 more

Ranked

1^st among 54 active competitors

Employee Count

23 as on Aug 31, 2026

Investment & Acquisitions

Durin Life Sciences

Similar Companies

OpenEvidence & 3021 more

View NeuroVision's full profile

NeuroVision is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Neurovision Imaging, Inc. CIN: 4873547 , United States, Active		-	13 (As on Dec 31, 2017)	-
NEURO VISION IMAGING CIN: 273554764 , United States, Active	Dec 31, 2009	-	7 (As on Dec 31, 2024)	-

NeuroVision has raised a total funding of $20.4M over 7 rounds. Its first funding round was on Jul 15, 2013. Its latest funding round was a Series C round on Aug 24, 2021 for $*****. 1 investor participated in its latest round. NeuroVision has 8 institutional investors.

Here is the list of recent funding rounds of NeuroVision:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 24, 2021	5124873	Series C	4084591	6379334	2626262	8775074
Feb 02, 2021	6536309	Series C	7715980	1680529	9642598	Alzheimer's Drug Discovery
May 02, 2018	2708773	Series C	6349146	6123186	Wildcat Capital Management	Vspglobal & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of NeuroVision's funding rounds and investors

The founders of NeuroVision is Steven Verdooner. Steven Verdooner is the CEO of NeuroVision.

Here are the details of NeuroVision's key team members:

Steven Verdooner: Co-Founder & CEO of NeuroVision and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address

NeuroVision's Board of Directors

NeuroVision's board has 6 active members. Steven Verdooner, Eric Johannessen, Nick Stonnington, Keith Black, James Thomas and Leonard Potter are independent board members.

Here is the list of NeuroVision's board of directors:

Name	Type	Representing	Status	Duration
Steven Verdooner	Independent board member	-	Current	15y 9m
y{dcfwr	Independent board member	-	Current	8y 3m
qveqgwh	Independent board member	-	Current	9y 2m
y{zdwny	Independent board member	-	Current	3y 2m
racip{z	Independent board member	-	Current	5y 7m
wzkbbev	Independent board member	-	Current	8y 7m

View details of NeuroVision's Founder profiles and Board Members

NeuroVision's employee count trend

NeuroVision has 23 employees as of Aug 26. Here is NeuroVision's employee count trend over the years:

Uncover NeuroVision's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroVision include Augmental Tech, Openwater and BrainSpace. Here is the list of Top 10 competitors of NeuroVision, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NeuroVision 2010, Sacramento (United States), Series C	Provider of telehealth platform offering diagnostic and preventative neurology services	$20.4M	Wildcat Capital Management, Janssen Pharmaceutica ... & 6 others	56/100
2nd	Augmental Tech 2018, Somerville (United States), Seed	Provider of an AR based solution to discreet hands-free mobile device interaction	$105K	Berkeley SkyDeck, MassChallenge & 1 others	52/100
3rd	Openwater 2016, San Francisco (United States), Series C	Provider of imaging technologies for medical diagnosis and treatments	$100M	Bold Capital Partners, Khosla Ventures & 10 others	49/100
4th	BrainSpace 2021, Bothell (United States), Seed	Wearable ventricular drain monitoring solutions for physicians	$280K	Seattle Angel Conference, K1 Investment Management	45/100
5th	Rhaeos 2018, Evanston (United States), Series A	Developer of a noninvasive device to monitor CSF and manage hydrocephalus	$12.8M	Steele Foundation for Hope, Gener8tor & 15 others	42/100
6th	NIRSense 2019, Richmond (United States), Funding Raised	Developer of a platform for neurovascular conditions	-	Lighthouse Labs	40/100
7th	Advanced Brain Monitoring 1997, San Diego (United States), Early Stage	Provider of neuro-diagnostics devices for researchers and clinical trials	$1.24M	National Heart Lung and Blood Institute, NIDA ... & 2 others	40/100
8th	Stata DX 2022, Cambridge (United States), Seed	Provider of liquid MRI-based platform for neurological diseases	$6.38M	-	38/100
9th	Kandu 2013, New York City (United States), Series A	Provider of stroke recovery services utilizing brain activated therapy with personalized telehealth services	$32.4M	Ally Bridge Group, AMED Ventures & 2 others	37/100
10th	Blinktbi 2017, Charleston (United States), Series A	Innovating neurological disease management with non-invasive blink reflex technology	$8.46M	-	35/100